.Exelixis is actually surrendering on its cells element (TF)- targeting antibody-drug conjugate afte...
.Three full weeks after Roche's Genentech system ignored an SHP2 inhibitor contract, Relay Therapeut...
.Stoke Therapies' Dravet syndrome drug has actually been devoid of a predisposed grip, removing the ...
.Intense Biotech Partner Editor Gabrielle Masson provided the 2024 lesson of Fierce 15 champions on ...
.Novo Nordisk has axed its once-monthly double GLP-1/ GIP receptor agonist, ending (PDF) development...
.Merck & Co. has swiftly gotten back a number of the prices of its own Harpoon Therapeutics buyou...
.After BioMarin performed a springtime well-maintained of its pipeline in April, the company has dec...
.Major Pharmas stay stuck to the concept of molecular glue degraders. The current business to see an...
.A brand new international life scientific research credit rating company, termed Symbiotic Funds, h...
.Bristol Myers Squibb is axing yet another significant bet from the Caforio period, canceling a deal...